Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)

China flag China · Delayed Price · Currency is CNY
57.60
+0.97 (1.71%)
Apr 29, 2026, 3:04 PM CST
14.31%
Market Cap 7.48B
Revenue (ttm) 1.17B
Net Income (ttm) 219.90M
Shares Out 129.95M
EPS (ttm) 1.69
PE Ratio 41.16
Forward PE n/a
Dividend 1.00 (1.77%)
Ex-Dividend Date May 20, 2025
Volume 1,539,107
Average Volume 1,868,600
Open 58.18
Previous Close 56.63
Day's Range 56.07 - 58.18
52-Week Range 50.02 - 94.30
Beta 0.66
RSI 44.94
Earnings Date Apr 21, 2026

About SHE:300841

Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines. In addition, it exports its products. Chengdu Kanghua Biological Products Co., Ltd. was founded in 2004 and is based in Chengdu, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 620
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300841
Full Company Profile

Financial Performance

In 2025, SHE:300841's revenue was 1.17 billion, a decrease of -18.64% compared to the previous year's 1.43 billion. Earnings were 219.90 million, a decrease of -44.84%.

Financial Statements

News

There is no news available yet.